SEBI Issues Administrative Warning to CARE Ratings Over Disclosure Lapses

CARE Ratings has disclosed that it received an administrative warning from the Securities and Exchange Board of India (SEBI). The warning, dated March 24, 2026, follows an inspection that identified inconsistencies in the company's disclosure criteria during the period of May 1, 2024, to March 31, 2025. CARE Ratings stated in a filing on March 25, 2026, that this regulatory notice has no impact on its financial, operational, or other business activities.

SEBI Warning Issued

The administrative warning stems from disclosure inconsistencies found during SEBI's inspection. CARE Ratings has promptly communicated this development, assuring stakeholders that it does not alter the company's financial standing or operational capabilities.

Importance of Regulatory Scrutiny

While CARE Ratings has stated there is no immediate impact, regulatory warnings from SEBI highlight the critical need for strict compliance within the financial services sector. For a credit rating agency, maintaining clear disclosure standards and strong governance is essential for building and retaining market trust and credibility.

Previous Scrutiny and Governance History

This is not the first time CARE Ratings has faced regulatory attention. In December 2023, the agency received a similar administrative warning from SEBI concerning discrepancies found in a prior inspection (December 2021 - April 2023), which included incorrect rating committee notes and delayed reviews. The company has also been involved in significant governance-related events, including allegations of credit rating manipulation against its former MD, Rajesh Mokashi. SEBI had previously banned him, but the Securities Appellate Tribunal (SAT) and later the Supreme Court overturned the regulator's order, questioning SEBI's evidence and calling the action a 'misadventure'. SEBI has been intensifying disclosure rules for all credit rating agencies (CRAs) to boost transparency and protect investors.

Company Response and Transparency

CARE Ratings is expected to continue following SEBI's regulatory guidelines. The company plans to display details of this SEBI warning on its official website, www.careratings.com, to ensure transparency with its stakeholders.

Potential Future Risks

Even if administrative, repeated warnings from SEBI could point to underlying compliance issues if not addressed thoroughly. Ongoing or recurring disclosure inconsistencies might lead to more severe regulatory actions in the future.

Industry Context

CARE Ratings operates within a landscape that includes peers such as CRISIL, ICRA, and India Ratings, all of whom are overseen by SEBI and subject to its disclosure mandates. While other rating agencies like CRISIL and India Ratings have also encountered scrutiny over rating actions, CARE Ratings' current focus is on its disclosure processes and adherence to regulations.

Key Dates

• Inspection Period: May 1, 2024 – March 31, 2025
• SEBI Communication Date: March 24, 2026
• Disclosure Letter Date: March 25, 2026

Investor Watchlist

Investors will likely check CARE Ratings' website for the disclosed information about the SEBI warning and any management comments. Future company filings will be important to determine if corrective actions have been effectively implemented to prevent recurrence of disclosure lapses. Any further communication from SEBI or stock exchanges regarding CARE Ratings' compliance procedures will also be closely watched.